Literature DB >> 22771168

Functional stability of Foxp3+ regulatory T cells.

Maria da Silva Martins1, Ciriaco A Piccirillo.   

Abstract

Significant evidence demonstrates that CD4(+) regulatory T cells (T(reg)) expressing the Forkhead box P3 (Foxp3) transcription factor are a distinct lineage of CD4(+) T cells that are essential for maintaining self-tolerance and modulating immunity to various nonself-antigens under changing inflammatory settings. Stable Foxp3 expression ensures T(reg) function in a variety of inflammatory contexts. However, the model of T(reg) cells as a stable, long-lived lineage is controversial. Whereas some studies have observed long-lived T(reg) function, recent studies suggest that T(reg) cells adapt to microenvironmental changes and consequently manifest functional plasticity by reprogramming into inflammatory T cells. Here, we review the evidence addressing the functional stability or plasticity of Foxp3(+) T(reg) cells and the implications for immune homeostasis and disease.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22771168     DOI: 10.1016/j.molmed.2012.06.001

Source DB:  PubMed          Journal:  Trends Mol Med        ISSN: 1471-4914            Impact factor:   11.951


  19 in total

1.  Lactobacillus reuteri DSM 17938 differentially modulates effector memory T cells and Foxp3+ regulatory T cells in a mouse model of necrotizing enterocolitis.

Authors:  Yuying Liu; Dat Q Tran; Nicole Y Fatheree; J Marc Rhoads
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-05-22       Impact factor: 4.052

Review 2.  Restoring homeostasis of CD4⁺ T cells in hepatitis-B-virus-related liver fibrosis.

Authors:  Li-Sha Cheng; Yun Liu; Wei Jiang
Journal:  World J Gastroenterol       Date:  2015-10-14       Impact factor: 5.742

3.  Immunoevasive pericytes from human pluripotent stem cells preferentially modulate induction of allogeneic regulatory T cells.

Authors:  Hagit Domev; Irina Milkov; Joseph Itskovitz-Eldor; Ayelet Dar
Journal:  Stem Cells Transl Med       Date:  2014-09-09       Impact factor: 6.940

Review 4.  Treg functional stability and its responsiveness to the microenvironment.

Authors:  Joseph Barbi; Drew Pardoll; Fan Pan
Journal:  Immunol Rev       Date:  2014-05       Impact factor: 12.988

5.  The regulation of regulation: interleukin-10 increases CD4+ CD25+ regulatory T cells but impairs their immunosuppressive activity in murine models with schistosomiasis japonica or asthma.

Authors:  Lei He; Sha Zhou; Qianqian Qi; Ying Chi; Jifeng Zhu; Zhipeng Xu; Xuefeng Wang; Jason Hoellwarth; Feng Liu; Xiaojun Chen; Chuan Su
Journal:  Immunology       Date:  2017-09-21       Impact factor: 7.397

Review 6.  Review: The function of regulatory T cells at the ocular surface.

Authors:  William Foulsham; Anna Marmalidou; Afsaneh Amouzegar; Giulia Coco; Yihe Chen; Reza Dana
Journal:  Ocul Surf       Date:  2017-05-31       Impact factor: 5.033

Review 7.  Vaccine against autoimmune disease: antigen-specific immunotherapy.

Authors:  Robert P Anderson; Bana Jabri
Journal:  Curr Opin Immunol       Date:  2013-03-13       Impact factor: 7.486

8.  An inherently bifunctional subset of Foxp3+ T helper cells is controlled by the transcription factor eos.

Authors:  Madhav D Sharma; Lei Huang; Jeong-Hyeon Choi; Eun-Joon Lee; James M Wilson; Henrique Lemos; Fan Pan; Bruce R Blazar; Drew M Pardoll; Andrew L Mellor; Huidong Shi; David H Munn
Journal:  Immunity       Date:  2013-05-16       Impact factor: 31.745

9.  Neuropilin-1+ regulatory T cells promote skin allograft survival and modulate effector CD4+ T cells phenotypic signature.

Authors:  Mauricio Campos-Mora; Rodrigo A Morales; Francisco Pérez; Tania Gajardo; Javier Campos; Diego Catalan; Juan Carlos Aguillón; Karina Pino-Lagos
Journal:  Immunol Cell Biol       Date:  2014-09-23       Impact factor: 5.126

Review 10.  Clinical Outlook for Type-1 and FOXP3(+) T Regulatory Cell-Based Therapy.

Authors:  Silvia Gregori; Laura Passerini; Maria-Grazia Roncarolo
Journal:  Front Immunol       Date:  2015-11-25       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.